F9 and breast cancer: Using a human genome-wide CRISPR/Cas9 library it has been identified that loss-of-function of the coagulation factor IX (F9) gene prevents the cell cycle arrest and senescent-like phenotype induced by Palbociclib in MCF7 breast cancer.